Additionally, compounds such as β–carotene have been investigated for their neuroprotective properties and their ability to modulate AChE activity, potentially offering new avenues for Alzheimer’s disease treatment [11]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.